- Home
- LIVN vs GOF Comparison
LIVN vs GOF Comparison
Compare LIVN & GOF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LIVN
- GOF
- Stock Information
- Founded
- LIVN 1987
- GOF 2006
- Country
- LIVN United Kingdom
- GOF United States
- Employees
- LIVN N/A
- GOF N/A
- Industry
- LIVN Biotechnology: Electromedical & Electrotherapeutic Apparatus
- GOF Finance/Investors Services
- Sector
- LIVN Health Care
- GOF Finance
- Exchange
- LIVN Nasdaq
- GOF Nasdaq
- Market Cap
- LIVN 2.8B
- GOF 2.3B
- IPO Year
- LIVN 1993
- GOF N/A
- Fundamental
- Price
- LIVN $46.75
- GOF $15.24
- Analyst Decision
- LIVN Buy
- GOF
- Analyst Count
- LIVN 7
- GOF 0
- Target Price
- LIVN $67.14
- GOF N/A
- AVG Volume (30 Days)
- LIVN 568.1K
- GOF 789.2K
- Earning Date
- LIVN 02-19-2025
- GOF 01-01-0001
- Dividend Yield
- LIVN N/A
- GOF 15.42%
- EPS Growth
- LIVN 759.09
- GOF N/A
- EPS
- LIVN 0.43
- GOF N/A
- Revenue
- LIVN $1,241,739,000.00
- GOF N/A
- Revenue This Year
- LIVN $10.10
- GOF N/A
- Revenue Next Year
- LIVN $5.43
- GOF N/A
- P/E Ratio
- LIVN $109.15
- GOF N/A
- Revenue Growth
- LIVN 11.04
- GOF N/A
- 52 Week Low
- LIVN $43.15
- GOF $10.96
- 52 Week High
- LIVN $64.48
- GOF $16.76
- Technical
- Relative Strength Index (RSI)
- LIVN 31.46
- GOF 36.64
- Support Level
- LIVN $46.44
- GOF $15.02
- Resistance Level
- LIVN $49.32
- GOF $15.81
- Average True Range (ATR)
- LIVN 1.45
- GOF 0.18
- MACD
- LIVN -0.43
- GOF -0.05
- Stochastic Oscillator
- LIVN 11.85
- GOF 22.68
About LIVN LivaNova PLC
UK-based LivaNova was born of a combination between Cyberonics in the us and Sorin in Italy. The medical-device firm is primarily focused on cardiopulmonary solutions (with heart-lung machines and oxygenation equipment) as well as neuromodulation devices for treatment-resistant epilepsy and depression. Following the merger, LivaNova divested its cardiac rhythm management and heart valve businesses. It derives roughly half of its revenue from the us market, another 21% from Europe, and the remainder from the rest of the world.
About GOF Guggenheim Strategic Opportunities Fund of Beneficial Interest
Guggenheim Strategic Opportunities Fund is a diversified, closed-end management investment company. The investment objective of the firm is to maximize total return through a combination of current income and capital appreciation. The Fund seeks to combine a credit-managed fixed-income portfolio with access to a diversified pool of alternative investments and equity strategies.